Development of novel immunotherapy strategies for the treatment of colorectal cancer using self-replicating RNA-based vectors.
Researcher | Principal Investigator Cancer gene therapy research group
Gene Therapy and Regulation of Gene Expression
Cancer Gene Therapy and Cholestatic Genetic Diseases
- Reference: PI17/01859
- Duration: 3 years
- Start date: January 1, 2018
- End date: December 31, 2020
- Funder: Instituto de Salud Carlos III (FIS)
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us